Dr. Patil is a medical doctor, a humanitarian, a serial entrepreneur and a yogini. Her sincere belief in her products and passionate commitment to creating a healthier, more conscious world has led her to design some of the most effective alternative treatment solutions in the world, for a number of clinical conditions, with a primary focus on Cancer and Pain. Her confidence in these advances has inspired her to commit all of her efforts into improving the quality of healthcare globally. While being a catalyst for humanity to realize their full potential, Dr. Patil brings the necessary expertise and experience to firmly establish GreenTech Laboratories, Inc. in the hearts and minds of physicians and patients alike.
Boasting a Western Medical Education & Clinical Training with over 20 years of clinical experience, Dr. Patil has co-founded two integrative medical centers specializing in clinical applications of Cannabinoids, Ayurveda and Botanical Medicine. Over the years, she has cared for over 62,000 patients using integrative medicine practices involving cannabis, Ayurvedic herbs, botanicals and specific treatment protocols. Dr. Patil has also led a specialized biotech diagnostic company and laboratory where she developed specialized bio-immune diagnostic assay markers and phyto-analytics. Additionally, she has consulted for various companies in the pharmacy sector.
In 2012, Dr. Patil received the first permit issued for cannabis R&D from the city of Berkeley, California where she developed a portfolio of over 32 drugs for different disease states. Dr. Patil has also developed an aesthetic product line for different conditions based on the foundational human constitution of Ayurveda and a 12-product nutritional supplement line. During her time in Berkeley, Dr. Patil developed the entire beta platform of agronomy, manufacturing, extraction, analytical lab, packaging and labeling and case study data collection that would later be scalable to a fully functional Bio- Pharmaceutical company. Dr. Patil is also linked to top leading regulatory agencies including the: FDA, NIH, NCI, NCCAM, NIDA, USNCAB, AYUSH, ICRS
Dr. Glen Rein, PhD has a strong academic background at institutes like Harvard and Mt. Sinai Medical Schools, culminated with a PhD in bio(neuro)chemistry from the University of London, and a post-doc publication on bioelectromagnetics published in Nature. Dr. Rein has 14 years experience as head of R&D for Estee Lauder Cosmetics with strategic corporate experience in discovering, targeting and applying new technologies and bio-actives for conception and creation of breakthrough personal care products. He has a proven record in directing and conducting innovative, patented/published, cutting-edge scientific research for claims substantiation of new products. With a grant from the Fetzer Institute Dr. Rein established the Quantum Biology Research Lab, currently located in Colorado. The lab does pioneering research into the nature of role of subtle energies in the body and offers contract research for clients. Dr. Rein has been published in numerous scientific publications and is a distinguished board member of several international organizations and professional societies. He has lectured in Israel, France, England and Russia on his innovative research. He has appeared on national radio and television in Canada, England and America.
Dr. Mahendra received his PhD in Natural Product Chem- istry from Adhra University, and masters M.phil (Phyto Chemistry) and M.Sc (Organic Chemistry) from Acharya Nagarjuna University and Andhra University respectively. He has over 18 years experience in the area of Industrial R&D, Process Development, New Product Development and Operations in the Nutraceutical / Herbal / Natural Products Industry. He has published 18 research papers and holds 6 patents; has been a research scientist at Central Tobacco Research Institute (CTRI), a Sr. Scientist at Biotech Elite Research and Innovations Sdn Bhd and BioPharma Laboratories Pvt. Ltd, and is currently Principal Scientist-R&D, responsible for Process Development and QC at Arjuna Natural Extracts Ltd.’
Amar Patel received his B.S. in Agronomy in 2007 from Iowa State University and has 7 years of experience working in the agricultural industry. In his 5 years working for Dupont, Amar managed a team running millions of samples per day in the genotyping process. He gained invaluable experience in some of the most advanced laboratories in the world defining extraction processes, constantly refining SOPs for greater efficiency, determining necessary DNA accuracy levels, and creating robust assay methods to handle DNA ranges. He received an International Recognition Award for establishing a large-scale recycling program, and was the first person at Dupont to receive a Core Values award. He is a passionate plant breeder and has created 12 hybrid cannabis strains. Amar has been a lifelong gardener with experience in many crop species.
Dr. Jiwan received his PhD in plant molecular biology from Washington State University in 2011. He has over 8 years of experience in generating and analyzing data using next generation sequencing. His post- doctoral experience includes developing techniques to facilitate faster alternatives to traditional breeding and developing genomic and transcriptomic data for rosaceous crops, wheat and tomato, using second generation sequencing (Roche 454, ion Torrent, Ion Proton and Illumina). Dr. Jiwan has more than six years of post-bachelor’s degree experience in molecular biology and plant tissue culture. He is proficient in molecular biology techniques, plant tissue culture and transformation using agrobacterium as well as biolistic gun. He is experienced in experimental de- sign and implementing tools and techniques to identify genes of agronomical important traits. He gained leadership, teamwork and communication experience through co-founding Phytelligence, holding presidential positions in international clubs, leading teams in his work environment, assistant teaching.
Viola studied pharmaceutical chemistry at Università Statale in 2010, and received a BSc honors (neuroscience) from Dundee University in 2013. She is currently studying Data analysis and statistical inference specialization at Duke. At the Centre for Neuroscience, Ninewells Hospital and Medical School, Viola did research on localization, intracellular signaling, and pharmacology of orphan lipid sensing G-protein coupled receptor GPR92. During that research she successfully identified novel endogenous agonist to the receptor (ligand screening, cytochemistry), proposed a drug profile for next generation anti-nociceptive drugs based on Calcium imaging screening and pCREB staining, and prepared, presented, and defended her research dissertation with 3 experts in the field and poster at Edinburgh University Neurological Society with over 200 scientists.
In 2012, also at the Centre for Neuroscience, Viola investigated of signaling and pharmacology of novel cannabinoid lipid sensing receptor (GPR55). She performed and analyzed experiments, did extensive ligand screening leading to the successful characterization of a GRP18 agonist. During this time she collaborated with leading cannabinoids cannabinoids Research Laboratory at Indiana University and Dundee University.
Viola has experience in good lab practices (GLPs), cannabinoid research, fluorescence microscopy, statistical analysis and R language, mammalian cell culture, Pharmacokinetics/Pharmacodynamics bioanalysis, in silico genome sequencing, DNA amplification, cloning, and PCR amplification.
Stuart Smith is a graduate from the University of Illinois holding a Bachelor’s Degree in Art and Design. With over 15 years experience working in marketing agencies in Chicago, Stu has held many leading roles in creative design, multimedia and production. His work history includes an extensive project list that spans across many mediums such as web, interactive, print, photo and broadcast. His career started at Upshot Marketing the year they won the best promotional ad company of the year from Promo Magazine. The clients he worked on during this time included TAP Pharmaceuticals, SBC Yahoo, P&G, Disney Vacations Club, Ford, Discover Card. Stu will be responsible for art direction and development for GTL’s product branding, marketing collateral, advertising, packaging, web and application development.
Marcos Gonzalez has over 23 years of experience in the manufacturing of medical devices and pharmaceuticals. He is accomplished in the development and deployment of new technologies and manufacturing methods, and in performing all of the tasks required for product submissions to the FDA and other regulatory agencies. By engaging in numerous hours of volunteer service in universities, healthcare facilities and government agencies, Marcos has developed excellent relationships within the medical industry, and has worked with many of the industry leaders in the medical device, pharmaceutical and the scientific communities. He has provided consultation services for pharmaceutical companies producing pilot batches, stability batches and product performance qualifications requiring technology transfers into full-scale production at customer sites. He has filed 6 patents to date as the inventor.
Arjuna is a mycologist and horticulturist with over 15 years of experience of growing medical cannabis, developing organic and vegan nutrient and soil formulations, as well as a wide array of national and international agricultural consulting. Arjuna’s specialties are large-scale indoor production, greenhouse production, soil and tea formulations, integrated facility design, production systems and production operations consulting. Arjuna is the CEO and Founder of Cannabliss Company.
Dr. Lyerly is the George Barth Geller Professor of Cancer Research, Professor of Surgery, Associate Professor of Pathology and Assistant Professor of Immunology at Duke University in North Carolina. He was appointed in 2008 by President George Bush to serve on the National Cancer Advisory Board, which oversees the National Cancer Institute. He currently serves on the Global Health Sub-Committee of the National Cancer Advisory Board. He has also been named to the National Institute of Health Council of Councils, and the Board of the National Institute of Health Office of AIDS Research. He has been a member of the Scientific Advisory Board of the Susan G. Komen for the Cure Foundation and the Burroughs Wellcome Foundation.
Dr. Lyerly is a highly sought after consultant and advisor and has served on Cancer center external advisory boards for MD Anderson, University of Michigan, University of Chicago, University of Alabama, University of Arizona, Boston University and Purdue. He has served as an advisor to the University of Washington, and Case Western Reserve Clinical and Translational Science Institutes.
Dr. Lyerly is an internationally recognized expert in cancer therapy and immunotherapy. He has published over 300 scientific articles and book chapters, and has edited 10 textbooks on surgery, cancer immunotherapy, and novel cancer therapies. He serves on the editorial board of 12 scientific journals.
Dr. Lyerly has been actively involved in cancer research education in Asia for over 10 years. He has research collaborations in cancer care, cancer immunotherapy, and cancer genomics with faculty members in China. He has been a faculty member of the Medical Oncology Group of Australia’s Clinical Trials Workshop, and has conducted clinical trials workshops in Singapore, China, India and Pakistan.
Dr. Lyerly currently leads a workshop with the US Food and Drug Administration directed to accelerating entry in the markets for cancer treatment.
Dr. Stephen Banister has enjoyed living and practicing medicine in Nevada County, CA for over 36 years, providing full spectrum primary care, holistic medicine, pain management and Cannabinoid health Care. Dr. Banister pioneered the integration of medicinal cannabis into his primary care practice in 1996 with the passage of proposition 25. His years of experience treating chronic pain, migraines, PTSD, ADHD and persistent muscle spasms with medical marijuana have made him an expert in the field. Dr. Banister is regularly called upon to educate doctors, lawyers and patients about the safety and effectiveness of medical marijuana. He testifies in court on behalf of his patients and their rights to access and use medicinal cannabis.
After earning degrees from the University of Michigan in the fields of Math, Engineering, Biophysics and Emergency Medicine and studying numerous adjunct healing modalities in Ann Arbor, Prashanti moved to India in 1990 to study Advaita and the Vedic Sciences including Ayurveda, Vastu shastra, Yoga, Jyotish, etc. He experienced the good fortune of a decade of sitting at the feet of epic paragons like Sri H.W.L. Poonja, Annamalai Swami, Lakshman Swami, the Dalai Lama, Urgen Tulku, Jamgong Kontrul Rinpoche, Hart de Fouw, Kaviraj Vaidya Nanakchand Sharma; as well a dozens of eminent yogis, priests, scientists. Traveling all over India training as a Yogi, Clinician and an Ethnopharmacologist, Dr. Prashanti De Jager settled in Lucknow, North India, where he started to treat hundreds of locals and foreigners that came to him with a vast number of health issues.
To ensure high quality formulas for his clients he started an Ayurvedic herb company in 1993 in North India where he grew, wild-crafted and processed the herbs by hand. As the reputation for these herbs grew worldwide, a beautiful team vision called Organic In- dia emerged to serve the demand in a socially responsible and environmentally sustainable way. Now thousands of farms in Northern India are transformed helping the farmers to lift the land out of the dire straits of the chemical / Monsanto mentality and into the realms of certified organic, Biodynamic, Fair Trade, Agnihotra herbal havens. Concurrent projects, such as the Dunagiri Foundation Trust, instill sustainable herbal wildcrafting amongst thousands of tribals in central India and also in the fragile ecosystems of the High Himalayas.
These projects earned Organic India the award for “The Most Socially Responsible Company,” in the entire Natural Products Industry of about 25,000 companies.
KDV is a nationally recognized, AV-rated® law firm serving the business community in a number of practice areas. Originally founded over 25 years ago as a labor and employment law firm, KDV has established a strong reputation in areas of commercial litigation, directors and officers liability (D&O) and professional liability coverage and defense. The firm’s attorneys are seasoned legal practitioners and litigators who place clients first, think like business people, and provide viable, innovative solutions.
Tad Devlin is a litigation partner in the San Francisco office of Kaufman Dolowich & Voluck, a national law firm with a litigation specialization, serving the business and insurance communities. Mr. Devlin has extensive experience handling all aspects of litigation in state and federal courts, including trial, post-trial and appellate practice, as well as alternative dispute resolution. He also has experience with business and commercial contract review and drafting in a variety of settings, including review of and advice regarding ERISA and non-ERISA governed benefit plans (e.g., Pension, ESOP, PSP, life, health and disability, and AD&D), as well as consulting and advising businesses on risk management, claim and litigation avoidance.
In addition, Mr. Devlin has handled bankruptcy court matters (Chapter 7, 11 and 13), including adversary proceedings, and stay relief. Mr. Devlin has defended and counseled individuals and businesses in state and federal government enforcement actions in criminal and civil matters, professional liability matters, and financial services matters, lending and banking disputes, construction and contract disputes, landlord/ tenant and real property disputes, corporate malfeasance, and enforcement of judgments and debts. He has also defended and counseled corporate and individual clients concerning corporate bribery, improper kickbacks and embezzlement.